Venu Holding Corporation — Form 8-K Summary
Business context and reporting period
Venu Holding Corporation filed a Form 8-K dated September 23, 2026, reporting the results of its 2026 Annual Meeting of Shareholders held that day. The filing was signed on September 24, 2026. The company is an emerging growth company, and its common stock trades on NYSE American under the symbol VENU.
Financial metrics and liquidity
This filing does not provide revenue, earnings, cash flow, margins, debt balances, liquidity measures, or other operating financial metrics. It references a July 2026 debt-financing transaction with YA II PN, Ltd. involving senior secured convertible debentures and warrants, but does not provide the financing amount, terms, outstanding balance, or interest rate.
Material changes versus the prior comparable period
- Shareholders approved potential issuance of 20% or more of the company’s outstanding common stock in connection with the July 2026 debt financing. The issuance could become available if the company defaults under the Securities Purchase Agreement, the senior secured convertible debentures, or related warrants.
- Shareholders approved an amendment to the 2023 Omnibus Incentive Compensation Plan, increasing shares reserved for awards from 7,500,000 to 10,000,000. The amended plan became effective September 23, 2026.
- All seven director nominees were elected to serve until the 2027 annual meeting and until their successors are qualified.
- Shareholders ratified Grassi & Co., CPAs, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Guidance, outlook, risks, contingencies, and unusual items
- No financial guidance or operating outlook was provided.
- The principal disclosed contingency is potential substantial equity issuance following a default under the July 2026 debt-financing arrangements, which could result in significant dilution.
- The expanded incentive plan increases the number of shares available for equity compensation by 2,500,000 shares, or approximately 33.3% relative to the prior authorization.
- Annual Meeting quorum was established with 37,237,129 votes represented, equal to 63.25% of the 58,869,339 shares entitled to vote.
- The company posted a replay of the Annual Meeting webcast on its investor-relations website.
Key facts investors should verify
- Review the July 2026 Securities Purchase Agreement, senior secured convertible debentures, and warrants for principal amounts, conversion terms, default provisions, security interests, and potential dilution.
- Confirm the maximum number of shares issuable upon a financing default and the conditions that would trigger issuance.
- Review the full amended and restated incentive plan for award types, vesting provisions, share-count adjustments, and dilution implications.
- Compare the financing-related disclosures with the company’s latest periodic filing to assess debt, liquidity, and going-concern risk.
- Confirm director election vote margins and the implications of the 49,586 broker non-votes for each nominee.